| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,381 |
13,084 |
$1.26M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,414 |
3,071 |
$769K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,068 |
4,083 |
$190K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,152 |
2,076 |
$35K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,374 |
1,333 |
$28K |
| 80053 |
Comprehensive metabolic panel |
1,700 |
1,595 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
376 |
364 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,830 |
1,683 |
$15K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,753 |
2,069 |
$13K |
| 80061 |
Lipid panel |
587 |
576 |
$9K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
247 |
236 |
$9K |
| 81001 |
|
1,951 |
1,819 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
404 |
398 |
$7K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
87 |
77 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
73 |
71 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
225 |
216 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
164 |
80 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
48 |
12 |
$947.95 |
| 99223 |
Prolong inpt eval add15 m |
14 |
12 |
$796.44 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
77 |
42 |
$789.69 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
54 |
52 |
$562.96 |
| 85027 |
|
113 |
113 |
$553.11 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
39 |
39 |
$529.72 |
| 82248 |
|
93 |
91 |
$450.36 |
| 82607 |
|
24 |
24 |
$414.48 |
| 84484 |
|
42 |
36 |
$336.90 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
191 |
168 |
$264.60 |
| 74022 |
|
12 |
12 |
$253.70 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
27 |
27 |
$233.48 |
| 84466 |
|
16 |
14 |
$225.84 |
| 36415 |
Collection of venous blood by venipuncture |
2,633 |
2,441 |
$202.98 |
| 90682 |
|
21 |
12 |
$185.24 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
94 |
81 |
$131.78 |
| 83540 |
|
16 |
14 |
$92.76 |
| 84100 |
|
14 |
14 |
$61.10 |
| 81025 |
|
12 |
12 |
$33.21 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
170 |
82 |
$0.01 |
| 1159F |
|
17 |
13 |
$0.00 |
| 3078F |
|
23 |
14 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
22 |
15 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
148 |
97 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
151 |
74 |
$0.00 |
| 1126F |
|
162 |
89 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
14 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
19 |
12 |
$0.00 |
| 3074F |
|
19 |
12 |
$0.00 |